Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides

Completed · Not applicable · Has a placebo group

Conditions studied: Hypertriglyceridemia

In brief

The purpose of this study is to evaluate the cardiovascular and lipid effects of two doses of an omega-3 fatty acid concentrate in a group of people who normally are not treated for high lipids.

Key facts

Study ID

NCT00504309

Run by

Penn State University

People needed

28

Starts

2007-07-01

Expected to finish

2009-01-01

Last updated by the study team

2018-03-13

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• triglycerides 150-500 mg/dL
• age 21-65 years
• generally healthy
• body mass index (BMI) 20-39 kg/m2

You may not qualify if…

• smoking
• premenopausal (if female)
• use of hormone replacement or oral contraceptives
• use of lipid lowering or blood pressure medication
• hypertension (blood pressure > 150/95 mm Hg)
• peripheral vascular disease
• heart disease, diabetes, or stroke
• inflammatory disease (e.g. rheumatoid arthritis or Crohn's)
• elevated liver enzymes
• high intake of omega-3 containing foods
• allergy to adhesive or latex
• use of aspirin, anticoagulants, or SSRI

Where it is running

• Penn State University General Clinical Research Center — University Park, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.